Year: 2025

Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an agreement to acquire Dynavax Technologies Corporation (Dynavax), a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and differentiated shingles vaccine candidate. The acquisition augments Sanofi’s presence in adult immunization by bringing together Dynavax’s vaccines with Sanofi’s global scale, development capabilities and commercial reach. Dynavax’s adult hepatitis B vaccine HEPLISAV-B is currently marketed in the US and is differentiated by its two-dose regimen over one month, which enables high levels of seroprotection faster than other hepatitis B vaccines, which are given in three doses over six months....

Elis announces a share capital decrease by way of treasury shares cancellation Puteaux, December 24, 2025 – Elis, the global leader in circular services at work, announces a capital reduction through the cancellation of treasury shares. On December 23, 2025, the Management Board decided to proceed with the share capital decrease of Elis’s share capital, as authorized by the shareholders at the Shareholders’ Meeting of May 23, 2024 (30th resolution) and at the Shareholders’ Meeting of May 22, 2025 (26th resolution), by cancelling 4,705,107 treasury shares representing 1.98% of the share capital. All treasury shares cancelled were repurchased on the market under the Group’s share buyback program authorized by the shareholders (19th resolution of the Shareholders’ Meeting of May 23, 2024, and the 24th resolution of...

Faraday Future and RAK Digital Assets Oasis (also known as RAK Innovation City) have entered into a strategic non-binding MOU to collaborate across three key areas: AI, Web3 and embodied intelligence. The two parties intend to explore the joint establishment of research and innovation centers to build a forward-looking, demonstrative industrial ecosystem. FF delivered the FX Super One to RAK Innovation City, the second FX Super One delivery in the UAE. The first FX Super One user in the UAE is global football legend Andrés Iniesta. FF has completed the delivery and transaction process for the Company’s next FF 91 2.0 Futurist Alliance vehicle with Hebron Sher, Co-Founder & CEO of ZEVO, with an upcoming delivery ceremony in January 2026.RAS AL KHAIMAH, United Arab Emirates and LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) —...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV:CTM) (OTCQB:CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to announce the closing of its previously announced private placement (see news releases dated December 4, 2025 and December 19, 2025) consisting of Critical Minerals flow-through shares and National flow-through shares for total gross proceeds of $5,705,361.51. (the “Private Placement”). Pursuant to the Private Placement the Company issued 10,980,000 Critical Minerals flow-through shares at a price of $0.25 per share (each, a “CMFT Share”) for gross proceeds of C$2,745,000. Each CMFT Share comprises one common share of the Company (each, a “Common Share”) issued as a flow-through...

AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia Marketed under AQVESME brand name in the U.S. for thalassemia indication; PYRUKYND® (mitapivat) remains the U.S. brand name for PK deficiency indication  AQVESME expected to be available in late January 2026, following AQVESME REMS program implementation Company will host investor conference call and webcast tomorrow, December 24 at 8:00 a.m. ETCAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK)...

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development“) announces that, on December 18, 2025, Osisko Development acquired, indirectly through its wholly-owned subsidiary, Barkerville Gold Mines Ltd. (“BGM“), 8,571,429 units of Niobay Metals Inc. (“Niobay“) at a price of $0.14 per unit for an aggregate subscription price of $1,200,000.06, pursuant to a private placement completed by Niobay (the “Offering“). Each unit consisted of one common share of Niobay (each, a “Common Share“) and one Common Share purchase warrant of Niobay (each, a “Warrant“). Immediately prior to the Offering, Osisko Development owned or controlled: (i) indirectly through its wholly-owned subsidiary, BGM, 9,857,143 Common Shares,...

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it has closed its previously announced non-brokered private placement financing of common shares issued on a “flow-through” basis (each, a “Common Share”) for proceeds of $1,694,503 (the “FT Offering”). For more information on the FT Offering, please see the Company’s press release dated December 12, 2025, a copy of which is available under the Company’s SEDAR+ profile at www.sedarplus.ca. Pursuant to the FT Offering, QGold issued 4,841,437 Common Shares on a “flow-through basis” at a price of $0.35 per share. The securities issued in connection with the FT Offering are subject to a statutory four-month hold period, which expires on April 24, 2026. Completion of...

VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) — Winshear Gold Corp. (TSXV: WINS) (‘Winshear’ or the ‘Company’) reports that the Company has received final approval from the TSX Venture Exchange (the ‘TSX-V’) for the arms-length agreement with Peak Nickel Limited (“Peak Nickel”), a private UK registered company, whereby Winshear can earn a 100% interest in the 250km2 Portsoy Project, located in Aberdeenshire, Northeast Scotland (Map 1) (see news release dated August 11, 2025).   A technical report (the ‘Report’) entitled ‘NI 43-101 Technical Report for the Portsoy Nickel-Copper-Cobalt Exploration Project, Aberdeenshire, Scotland’, prepared under the supervision of independent Qualified Person Mr. Richard Siddle, MSc, MGeol, MAIG, Director and Principal Consultant of Addison Mining Services, UK, will be posted on the...

VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB. V), today announced that the Toronto Stock Exchange (“TSX”) has accepted its notice of intention to make a normal course issuer bid (the “NCIB”). The notice provides that AHIP may, during the twelve-month period commencing December 30, 2025 and ending December 29, 2026, purchase up to 6,801,276 units of AHIP trading under the symbols HOT.UN and HOT.U (each, a “Unit”), representing 10% of the “public float” (as defined in the TSX Company Manual) as of December 22, 2025. Daily purchases of Units under the NCIB will be limited to 10,938 Units (which is equal to 25% of the average daily trading volume of the Units on the TSX of 43,755 Units for the most recently completed six calendar...